Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays

@article{Boyd2008ProteomicAO,
  title={Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays},
  author={Z. Boyd and Q. J. Wu and Carol O'brien and J. Spoerke and H. Savage and P. Fielder and L. Amler and Y. Yan and M. Lackner},
  journal={Molecular Cancer Therapeutics},
  year={2008},
  volume={7},
  pages={3695 - 3706}
}
  • Z. Boyd, Q. J. Wu, +6 authors M. Lackner
  • Published 2008
  • Medicine, Biology
  • Molecular Cancer Therapeutics
  • Although breast cancer molecular subtypes have been extensively defined by means of gene expression profiling over the past decade, little is known, at the proteomic level, as to how signaling pathways are differentially activated and serve to control proliferation in different breast cancer subtypes. We used reverse-phase protein arrays to examine phosphorylation status of 100 proteins in a panel of 30 breast cancer cell lines and showed distinct pathway activation differences between… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 52 REFERENCES
    Analysis of signaling pathways in 90 cancer cell lines by protein lysate array.
    31
    Reverse-phase protein microarrays for theranostics and patient tailored therapy.
    38
    Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer.
    96
    Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study
    287
    Repeated observation of breast tumor subtypes in independent gene expression data sets
    4877